| REVIEW ARTICLE |
|
| Year : 2013 | Volume
: 54
| Issue : 5 | Page : 289-294 |
|
|
Recombinant activated factor VII in post partum haemorrhage
Navneet Magon1, KM Babu2, Krishan Kapur3, Sanjiv Chopra4, Gurdarshan Singh Joneja5
1 Department of Obstetrics and Gynecology, Air Force Hospital, Jorhat, India
2 Department of Obstetrics and Gynecology, Command Hospital (AF) Bangaluru, India
3 Department of Obstetrics and Gynecology, Army Hospital (R and R) Delhi, India
4 Department of Obstetrics and Gynecology, Military Hospital, Meerut, Uttar Pradesh, India
5 Department of Obstetrics and Gynecology, Sikkim Manipal Medical College, Gangtok, Sikkim, India
Correspondence Address:
Navneet Magon
Obstetrician-Gynaecologist and Endoscopic Surgeon, Head, Department of Obstetrics and Gynecology, Air Force Hospital, Jorhat, Assam
India
 Source of Support: None, Conflict of Interest: None  | Check |
DOI: 10.4103/0300-1652.122328
|
|
|
Post-partum haemorrhage (PPH) is a life-threatening obstetric complication and the leading cause of maternal death. Any bleeding that results in or could result in haemodynamic instability, if untreated, must be considered as PPH. There is no controversy about the need for prevention and treatment of PPH. The keystone of management of PPH entails first, non-invasive and nonsurgical methods and then invasive and surgical methods. However, mortality remains high. Therefore, new advancements in the treatment are most crucial. One such advancement has been the use of recombinant activated factor VII (rFVIIa) in PPH. First used 12 years back in PPH, this universal haemostatic agent has been effectively used in controlling PPH. The best available indicator of rFVIIa efficacy is the arrest of haemorrhage, which is judged by visual evidence and haemodynamic stabilization. It also reduces costs of therapy and the use of blood components in massive PPH. In cases of intractable PPH with no other obvious indications for hysterectomy, administration of rFVIIa should be considered before surgery. We share our experience in a series of cases of PPH, successfully managed using rFVIIa. |
|
|
|
| [FULL TEXT] [PDF]* |
|
 |
|
